EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

TPS38 - Dermatology 02

Saturday 14 Jun, 12:00 PM - 13:00 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
000587
Generalized Acute Eosinophilic Folliculitis Induced by Drugs in an Oncology Patient
D2.299
A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.305
Acute generalized exanthematous pustulosis due to iohexol with tolerance to iobitridol
D2.296
Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
D2.294
Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
D2.303
Blistering Discovery: A Rare Case of Toxic Epidermal Necrolysis Triggered by Carboplatin and Radiotherapy
D2.295
Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
D2.307
Diagnostic characterization of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): Case series from a tertiary care hospital and literature review
D2.308
Evaluation of ChatGPT Responses to Frequently Asked Questions by Parents of Children with Atopic Dermatitis
D2.300
Fixed Drug Eruption related to the use of NSAIDs
D2.302
Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test
D2.297
SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
D2.306
Sodium dodecyl sulfate impairs the skin epithelial barrier by inducing oxidative stress in human skin
D2.304
Transepidermal Water Loss in Atopic Diseases

Chairs

Speakers